The structure, function, and pharmacologic inhibition of FGF23

Research Faculty & Summary

Joseph Schlessinger, Principal Investigator
V.P. Eswarakumar, Co-investigator

FGFs mediate their responses by binding to and activating a family of four receptor tyrosine kinases (FGFRs 1 – 4). FGFRs 1 – 3 have two isoforms produced by alternate splicing which differ in their ligand-binding specificities and tissue expression patterns.

Download Entire Publication as PDF